Article Information
History
- July 6, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Laura Mannonen*,+,
- Hannimari Kallio-Kokko*,
- Raisa Loginov*,
- Anu Jääskeläinen*,
- Pia Jokela*,
- Jenni Antikainen*,
- Paula Väre*,
- Eliisa Kekäläinen*,†,
- Satu Kurkela*,
- Hanna Jarva*,†,‡ and
- Maija Lappalainen*,‡
- *HUS Diagnostic Center, HUSLAB, Clinical Microbiology, University of Helsinki and Helsinki University Hospital, Finland
- †Translational Immunology Research Program and Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland
- ↵+Corresponding author: Laura Mannonen, HUS Diagnostic Center, HUSLAB, Clinical Microbiology, POB 720, 00029 HUS, Finland. E-mail: laura.mannonen{at}hus.fi
↵‡ equal contribution
Posted July 06, 2020.
Comparison of two commercial platforms and a laboratory developed test for detection of SARS-CoV-2 RNA
